Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01288703 · ClinicalTrials.gov registry record
Computerized-Adaptive Testing: Feasibility In Women With Pelvic Floor Disorders (CAT)
A clinical trial of Urinary Incontinence, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT01288703: Completed study of Urinary Incontinence, sponsored by Women and Infants Hospital of Rhode Island.
NCT01288703 is a study of Urinary Incontinence that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 20 participants, below the 262-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01288703, a study of Urinary Incontinence, has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this pilot-study is to evaluate the feasibility and acceptability of PROMIS computerized-adaptive testing in women with urinary incontinence.
Primary Outcome
To test the feasibility and acceptability of PROMIS and Computerized-Adaptive Testing (CAT) technology in women with Urinary incontinence. In recruiting sixty women, we will conduct pilot-testing on the CAT mode of the PROMIS questionnaires, and compare participant's attitudes about the paper short-forms versus the CAT modes of administration.
Conditions Studied
Study Locations (1)
Rhode Island
- Women & Infants Hospital Division of Urogynecology - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-02 |
What the finished NCT01288703 record still lists
NCT01288703 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 262-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Urinary Incontinence appearing as the primary indexed condition, and to 0 interventions.
NCT01288703 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT01288703 about?
NCT01288703 is a clinical study titled "Computerized-Adaptive Testing: Feasibility In Women With Pelvic Floor Disorders (CAT)". The objective of this pilot-study is to evaluate the feasibility and acceptability of PROMIS computerized-adaptive testing in women with urinary incontinence.
What is the current status of trial NCT01288703?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2010-08. Estimated completion is 2012-02.
What conditions does trial NCT01288703 study?
This clinical trial studies the following conditions: Urinary Incontinence.
Who is sponsoring clinical trial NCT01288703?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01288703 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01288703's enrollment target sits among peer trials
20 41st of 48 higher than 5 of 48 other Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NXT Post-Market Clinical Follow-up
RECRUITING
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Training for Urinary Leakage Improvement After Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia